Itchy Skin Conditions? Novartis’ Pivotal Trial Success Shows Potential For Targeted Relief – Novartis (NYSE:NVS)
Novartis AG (NYSE:AG) on Wednesday released positive topline results from its pivotal Phase 3 RemIND trial of oral…
Browsing Tag